Abstract-This paper presents a bio-inspired method for in-vivo control of blood glucose based on a model of the pancreatic -cell. The proposed model is shown to be implementable using low-power analogue integrated circuits in CMOS, realizing a biologically faithful implementation which captures all the behaviours seen in physiology. This is then shown to be capable of glucose control using an in silico population of diabetic subjects achieving 93% of the time in tight glycemic target (i.e., [70, 140] mg/dl). The proposed controller is then compared with a commonly used external physiological insulin delivery (ePID) controller for glucose control. Results confirm equivalent, or superior, performance in comparison with ePID. The system has been designed in a commercially available 0.35 CMOS process and achieves an overall power consumption of 1.907 mW.
I. INTRODUCTION

D
IABETES Mellitus is one of the most rapidly growing chronic diseases in modern society affecting 3-5% of the total population on earth. It is normally characterized by an increase in blood glucose which occurs either because the pancreas does not produce enough insulin or because the produced insulin is not functional. Type 1 diabetes mellitus (T1DM), which amounts to 10% of the diabetic population is an autoimmune condition which results in complete destruction of insulin secreting -cells of the pancreas leaving the body unable to control its blood glucose. If left unmanaged, it can have long term side effects such as blindness, kidney failure and heart disease.
Current treatment of T1DM involves insulin injection after meals using an insulin pen or an insulin pump. Although this works in the short term, subjects T1DM still spend a large amount of time with high-blood glucose, or hyperglycaemia putting them at risk. The Diabetes Control and Complications Trial [1] demonstrated that intensive insulin management reduced complications by as much as 50-76%. The potential benefits of having an automated system to control blood glucose has lead to the development of the Artificial Pancreas. The Artificial Pancreas is a closed-loop system whose main role is replicate the function of a healthy human pancreas to improve control of glyceamia [2] shown in Fig. 1 . It normally comprises of:
• A continuous blood glucose sensor which is connected to the body either subcutaneously or intravascularly.
• An insulin pump that delivers insulin either subcutaneously or intravenously.
• A device which runs a control algorithm to relate the rate of delivering insulin with blood glucose level. The Biostator was one of the first artificial pancreas systems introduced 40 years ago [3] . Due to its intravenous nature, it was only used in the clinic by the patient bedside and was very useful in a wide range of medical studies such as assessment of the influence of drugs on health, on measurement insulin resistance using clamp techniques, and treatment assessment on surgical interventions. Since the initial creation of the Biostator there has been an evolution in portable subcutaneous continuous glucose monitoring (CGM) [4] and insulin pump technologies [5] , allowing subjects with diabetes to manage their blood glucose outside the hospital environment in an open-loop fashion. These are still sub-optimal however, with subjects still spending a large amount of time with high blood glucose levels. As a result there have been several attempts to create an artificial pancreas all working with existing subcutaneous glucose sensors and insulin pumps [2] , [6] . These, however, have to accommodate for delays of insulin absorption in the subcutaneous space and inaccuracies of glucose measurements making there adoption challenging [7] . More recently, we have seen the advent of peritoneal insulin pumps [8] , [9] and rapid acting insulin alternatives [10] which would potentially allow faster control of blood glucose with minimal delay. Furthermore, CGM technology is continuously improving [11] and new promising solutions are emerging [12] .
This work is licensed under a Creative Commons Attribution 3.0 License. For more information, see http://creativecommons.org/licenses/by/3.0/ Key to the realisation of an artificial pancreas is an electronic device which can bridge the glucose sensor and insulin pump and offer full closed-loop control. This should ideally replicate the behaviour of the -cells of the pancreas to be able to mimic insulin secretion. Additionally, it should be miniature to allow complete integration in a portable medical device. This can be facilitated by implementation on a CMOS microchip [13] , [14] .
Towards this goal, we present a bio-inspired method for treatment of T1DM, through an analogue implementation of the insulin secreting pancreatic -cell. We show its design using low-power integrated circuits in CMOS and follow on to show how this bio-inspired method can be used to control a FDA-accepted [15] virtual T1DM diabetic population comprising of 10 adults and 10 adolescents. Finally, we present a comparison between the bio-inspired approach and a commonly used blood glucose control technique. This paper is organized as follows. Section II describes the mathematical model of the -cell which is used for our bioinspired approach. Section III illustrates the analogue implementation and the analysis of each block of the system. Section IV presents the results of the circuit showing that it achieves comparable responses as observed in -cells. Finally Section V shows how this controls blood glucose in a type-1 diabetic population and how this compares to a conventional method of control. We conclude with a discussion on the benefits of our approach.
II. THE -CELL MODEL
The idea of using a physiological approach for blood glucose control was first postulated by Steil and colleagues [16] . In this work, a minimal model of insulin secretion, proposed earlier by Breda and colleagues, [17] was used for blood glucose control. This simple model represents the insulin secretion by decomposing it into a static rate of secretion, which basically depends on the plasma glucose concentration (second phase), and a dynamic secretion rate, which depends on the rate of change of plasma glucose concentration (first phase). Steil and colleagues [16] compared the minimal model of insulin secretion with a PID controller, the behaviour of which also exhibits biphasic response, and concluded that both were able to fit experimental data. However, the insulin secretion model was less stable than the PID controller under closed-loop conditions due to the simplification of the -cell model.
More recent developments of mathematical models of -cell physiology, [18] - [21] which are able to describe the glucose-induced insulin release at a molecular level, have opened the door to a new class of bio-inspired glucose control algorithms. Initial minimal models of insulin secretion such as the ones proposed in Hovorka and colleagues, [22] Toffolo and colleagues, [23] Cretti and colleagues, [24] Mari and colleagues, [25] and Breda and colleagues [17] are not able to represent some of the experimental data, probably because of their excessively simplistic structure. On the other hand, more sophisticated models such as the ones proposed by Pederson and colleagues, [18] Bertuzzi and colleagues, [19] and Chen and colleagues, [20] can be difficult to implement in a closed-loop controller because of their high number of parameters and equations. In 2008, a mathematical model for the granular release of insulin was reported [21] which is now being used as control algorithm for the Bio-inspired Artificial Pancreas (BiAP) [6] . This model is able to represent most of the experimental data, including the biphasic response of insulin secretion, the staircase modulation of insulin secretion, the potentiation effect of glucose, and the kiss-and-run effect of insulin secretion granules. Furthermore, its relative simplicity makes it convenient for practical closed-loop control implementation. Fig. 2 shows an overview of the model. In particular, the model introduces mobilization of secretory granules from a reserve pool to the cell periphery, where they attach to the plasma membrane (i.e., docking). The granules can mature further (i.e., priming), thus entering the readily releasable pool (RRP). The possibility of so-called kiss-and-run exocytosis is included, where the fusion pore reseals before the granule cargo is released. The model assumes that the beta cells have different glucose thresholds for triggering . Additionally the model assumes that a proportion of the cells remains silent and the remaining cells release insulin depending on the glucose value. This can be described by a density function given by (1) where is the current value of glucose and is a time-independent function and represents the proportion of triggered cells for each glucose value. The values for change when the value of basal glucose changes. For the evaluated scenarios of this work, the value for basal glucose was set at 100 mg/dl.
Mobilisation of the cells depends on the value of glucose with a delay of and is described by (2) where is the expression for the steady-state mobilisation and its response is a sigmoidal function (Hill equation) given by (3) Fig. 3 . Block diagram of the system, the glucose input in mV drives the transconductor and then the signal as current passes through block M and D to form the input for the block which computes the approximations of the integral terms of (4) and (7) as and , respectively. Then drives block F, a low pass filter whose output multiplied by m produces the insulin output in current.
where is the Hill coefficient, is the apparent dissociation constant of the Hill equation, is the basal mobilisation rate and is the maximal rate of stimulated mobilisation. The docked pool equation is given by (4) where is the rate of reinternalisation, is a time-varying density function which indicates the amount of insulin in the RRP. Triggered granules are fused with a rate of , hence we have (5) where and are the rates for priming and depriming of the granules, respectively. The function is the Heaviside unit step function which returns 1 if the input is greater than zero and 0 if the input is smaller than zero. The insulin secretion rate is given by (6) where is the basal insulin secretion (not shown in Fig. 2 ), is a rate constant and is the fused pool described as (7) where is a rate constant called kiss-and-run. More details for the model can be found at [21] .
III. AN ANALOGUE IMPLEMENTATION
This work presents an analogue implementation of the -cell model proposed by [21] . This circuit is an electronic realisation of the original -cell model equations which is achieved with the use of several blocks shown in Fig. 3 . This includes a transconductor to replicate the steady state mobilisation, followed by several low pass filters to implement time-dependant terms and then a block controlled by a thermometer coder in such a way to produce the approximations of integral terms of the model's dynamics. The output of this block finally drives another low pass filter and after a scaling with the use of a current mirror the final output of the system is produced representing the proposed amount of insulin.
The glucose input of the model, with a typical range of glucose levels variations from 0 to 500 mg/dl, is mapped as the voltage input of the circuit with a range of 0 -500 mV and drives the transconductor which mimics the response of ( (3)). Then, the signal is processed as indicated by the block diagram of the circuit presented in Fig. 3 , and ends up producing an output in the range of 0-6 nA corresponding to real insulin secretion values of 0-60
. We now proceed to explain how each function in the model was realized.
A. Transconductor
In order to replicate the function of as described in (3), the block would require adders, multipliers and dividers. Due to the complexity of building an electronic circuit to replicate the function of , another method to achieve the same output was adopted. In particular, the response of to an input glucose sweeping from 0 to 500 mg/dl, is a sigmoidal function [ Fig. 4(b), red line] .This sigmoidal function can be replicated by an area scaled differential pair transconductor. Fig. 4(a) shows the topology, in which two differential pairs with scaled transistor sizes (ratio 6:1 outer to inner) are being used in order to achieve the aiming linearity of . The achieved sigmoidal 
B. Bernoulli Cell Formalism for Low Pass Filters
The realisation of the model's time-dependant dynamics was performed with the use of the Bernouli Cell (BC) formalism [26] to implement log-domain filters. The BC and its non-linear aspect (NBC) [27] can produce the solution of linear and nonlinear differential equations (DE) of the form (8) where is the state variable, is the input, is a coefficient of the DE, is the subthreshold slope, C is the value of the capacitor and is the thermal voltage. The first order DE of -cell model are using constant in time coefficients and since the state variables can be represented by currents as the electronic equivalent of (8) is (9) This equation describes the function of circuit shown in Fig. 5 , where is the output current, is the input current, the ratios and represent the coefficients of the DE and and are biasing currents. The current sources are being used for biasing purposes and are placed in such a way in order to satisfy the translinear loop and not affect the DE. The dynamics of -cell model described by (2) , (4), (5), (7) can be represented in the form of (9) as follows: (10) (11) (12) (13) (14) where actRRPT and actRRPG are the approximations of the integral terms of (4) and (7) expressed as and . The values of the parameters were taken from [21] . Table I summarizes the biasing currents and the values of the capacitors for every block describing the equations above. All the filters used are 1st order log-domain low-pass filters with a 20 db/decade attenuation realizing the same dynamics of (9). The circuit of Fig. 5 has been used to implement these with cutoff frequency ( ) and parameters summarized in Table I . Moreover large devices ( ) have been used for all transistors to ensure good matching and reliable translinear operation and currents have been chosen to be below 100 nA to guarantee weak-inversion operation.
C. Thermometer Coder
and are the inputs of the subsystems block F and block D, respectively shown in Fig. 3 . is the sum of all outputs of blocks and since are currents the sum of them can be easily extracted by driving them all to the same node.
is the sum of outputs of blocks whose glucose thresholds are lower than the glucose input of the system. Thus a thermometer coder to control the state of the switches ("open", input higher than glucose threshold, "close" input lower than glucose threshold) was used to drive the desired currents in the same node in order to compute the value of . The same technique is used for the selection of either block or , the former is used for glucose input values higher than the glucose threshold while the latter for values lower than the threshold.
Ideally since the range of glucose is from 0 mg/dl to 500 mg/dl and the sensitivity is 1 mg/dl, a number of 500 comparators and pairs of h blocks were required. However, because the non-zero values of are only 200 (corresponding for glucose values from 100 mg/dl to 300 mg/dl), this number was decreased to 200.
As can be seen in Fig. 6 , the thermometer coder consists of 200 comparators where each of them compares the input voltage (the input glucose of the system) with a different threshold voltage. This different threshold voltage replicates the different glucose threshold for every block. This implies that depending on the input voltage, the output of the comparators that have a threshold voltage lower than the input voltage will be one (closed switch), while the ones with a threshold voltage higher than the input voltage will be zero (opened switch).
D. Multiplier
A multiplier was designed to perform the internal computations between the main blocks of the system. Most of the internal computations were multiplications, between an input and a constant parameter. For that reason a current mirror with scaled transistor sizes was preferred instead of a translinear multiplier. However, a translinear multiplier cell was designed in order to apply the multiplication of and . The result of this multiplication is the input of block . In this occasion a current mirror is not possible to be used, since is an internal variable signal and is an input of the system. Fig. 7 shows the translinear multiplier cell. The red arrows in Fig. 7 indicate the transilinear loop which is described by (15) . (15) scales down the product of the multiplication by factor of 1 nA.
IV. CIRCUIT RESULTS
The circuit was designed in the commercially available 0. 35 CMOS technology with an operating power supply (Fig. 8(a) ] : The input glucose is taken from a real meal scenario as proposed in [21] . • 3 Meals Scenario [ Fig. 8(b) ]: A computer simulation environment [15] was used to simulate a typical glucose response of a T1DM subject to a meal scenario consisting of 3 meals (i.e., breakfast, lunch, dinner) containing 40 g, 60 g and 50 g of carbohydrates, respectively. On the insulin secretion figures, the green solid line represents the response from Matlab and the magenta dashed line the result from the circuit. These results demonstrate the close matching of the circuit responses with the corresponding ones from Matlab. The minor mismatch at the output of the circuit is the result of the switching performance for the creation of . A minor delay which exists between the switching states (openclose) causes a distortion to the response. In Fig. 8(d) , it is worth noting the close matching of the response from Matlab and the response from the circuit implementation, with a mean error of 0.0871 . Table II summarizes the measured power consumption of each block of the circuit. Despite the circuit complexity the power consumption has remained reasonably low due to subthreshold operation. The bottleneck of the circuit's power consumption lies with the number of comparators required in the thermometer coder, which can be replaced with a more power efficient solution.
V. COMPARISON WITH ePID CONTROLLER
To test the performance of the -cell model as a bio-inspired artificial pancreas controller (BIAP), a comparison with the ePID controller proposed by Medtronic (Northridge, CA, USA) [7] was carried out. To carry out such comparison, the FDA-accepted UVa-Padova T1DM simulator [15] was employed. In particular, the 10 adult and 10 adolescent virtual populations form the simulator were selected. The 10 paediatric subjects available in the UVa simulator have extreme glucose dynamics, and in-line with other studies have not been considered here [28] , [29] .The simulator was configured to sense blood glucose intravascularly and to deliver insulin intravenously. Although the intravenous route is not practical in an ambulatory setting (e.g., cannula occlusions), the advent of new insulin delivery routes [8] , [9] , rapid acting insulin alternatives [10] and CGM technologies [12] , make this assumption not that unrealistic.
Since the glucose sensing and insulin delivery route was selected, the insulin feedback term in the ePID controller, which is designed to compensate delays due to the subcutaneous route, was not required. Therefore, the equations representing the employed ePID controller are (16) (17) (18) (19) where , , and denote the proportional, integral, and derivative terms of the PID algorithm; denotes sensor glucose; is the glucose set point; denotes the rate of change of ; and , and are tuning parameters. was set to the basal insulin delivery ( ) and its range was constrained by (20) (21) where , and . It is worth noting that these constraints may allow insulin delivery in the hypoglycemic range if glucose concentration is increasing rapidly.
Since the -cell model [21] employed in the bio-inspired controller does not incorporate basal insulin suppression at low blood glucose concentration levels, this effect was incorporated as follows: (22) where is tuneable gain for patient individualisation and is a variable gain defined as (23) being and constrained between . The patient individualization in the analogue implementation is easily achieved using a digitally programmable current mirror at the output, which receives a binary value of the parameter and then scales the output to as in (22) . Standard metrics provided by the UVa-Padova T1DM simulator, such as mean blood glucose (mean ), risk index ( ), selected glucose target range corresponds to the normoglycemic post-prandial glucose range in healthy subjects.
Both controllers were tested using a 24-hour scenario with an initial blood glucose of 140 mg/dl and containing 3 meals of 40 g, 60 g and 50 g of carbohydrates at times 6 am, 2 pm and 8 pm. Controller gains (BIAP) and (PID) were adjusted per subject in order to minimise hyperglycaemia and to avoid dropping below 80 mg/dl. Since only one parameter per controller was allowed to be individually tuned, parameters and were respectively fixed to 15 and 150 for all subjects. A sampling time of one minute was used for both controllers and the calculated insulin was delivered as a micro-bolus at each sampling time. Table III shows the results for the BIAP and ePID controllers corresponding the adult population. Table IV shows the results for both controller corresponding the adolescent population. Fig. 10 shows a graphical comparison of the BIAP and ePID controllers for the adult population and Fig. 11 shows the same comparison but for the adolescent population. It is worth noting that, although moderate improvement, all metrics show superior glycemic control of BIAP with respect to ePID.
It is worth noting that, on average, the BIAP controller outperformed the ePID controller in all the metrics. In particular, the percentage of time in target for the BIAP was 97.3% in the adult population and 89% in the adolescent population, compared to 93.5% and 85% for the ePID controller in respective populations. Although these differences may not seem numerically significant, they can represent a notable improvement in terms of the reduction on the number of hypoglycaemic events.
VI. CONCLUSION
We presented an analogue implementation of the pancreatic -cell model and showed its potential in controlling blood glucose in-vivo. The analogue implementation was implemented to faithfully recreate physiological responses seen in the -cells. We showed it capable of achieving comparable insulin release profiles for a glucose step, ramp, staircase and meal stimuli. In a typical control scenario it could control glucose for three meals (breakfast, lunch and dinner) achieving good % time in target.
Our bio-inspired approach using the -cell model captures quite accurately all effects seen in physiology to achieve physiological insulin delivery which has been shown to be impor-tant as it reduces both mitogenic any myogenic effects when controlling blood glucose [30] . Unlike the previous work by Steil et al. [16] , it has been proven that a bio-inspired glucose controller based on a model of the -cell physiology can provide equivalent, and in some cases superior, performance compared to a PID controller in the 10 adult and 10 adolescent virtual populations of the UVa-Padova simulator [15] . Moreover, as with other successful bio-inspired systems such as the cochlear [31] , we can implement our system in CMOS with circuits which operate in weak inversion, providing additional advantages of low-power and minaturisation. Furthermore, our bio-inspired method allows a more natural extension to developing a bi-hormonal system [32] , as is seen in physiology, by incorporating additional models of pancreatic cells such as the alpha cell which have been shown to be important for glucagon release, a counter regulatory hormone to insulin which can prevent hypoglycemia [33] .
The analogue implementation of the system in CMOS was optimized to achieve a power consumption of 1.907 mW. This was mainly due to the large number of comparators required to recreate a bio-realstic profile by keeping the glucose step at 1 mg/dl. Applying sampled data techniques to cycle and thus re-use common blocks would greatly minimise this and is subject to further work. Furthermore techniques of designing longtime constant -C filters [34] which can use on chip capacitors are promising for a future implementation of the proposed circuit on a chip. We also envisage that an analogue implementation such as this could act as a tool for better understanding and simulating clusters of -cells as has been done in the past for neural systems [35] and chemical reactions [36] . Though the current system is limited to in vivo use, with the future trend of implantable glucose sensors and rapidly acting insulin we envisage that it could be applied in the future for an implantable artificial pancreas. For current subcutaneous systems the algorithm has been adopted to work [6] creating a wearable bio-inspired artificial pancreas. This will ultimately lead to better control of blood glucose and impact on diabetes management, reducing complications and improving quality of life.
